Max Robotics — Global Service Robot Directory + US Certification

About

Matteo Lazzeroni is a pioneering breast surgeon whose work centers on advancing minimally invasive surgical techniques for breast cancer treatment. His most impactful contribution is the landmark randomized trial comparing robotic mastectomy to open surgery in women with breast cancer or BRCA mutations, which has garnered over 100 citations. This study provided critical evidence that robotic nipple-sparing mastectomy offers comparable oncologic safety while potentially improving cosmetic outcomes and quality of life. Lazzeroni’s research has helped establish robotic surgery as a viable, patient-centered alternative to traditional approaches, addressing key concerns around surgical morbidity and aesthetic preservation. Beyond this trial, his work explores the intersection of surgical innovation and patient-reported outcomes, aiming to refine techniques that reduce recovery time and enhance psychological well-being. Recognized for bridging cutting-edge technology with rigorous clinical evidence, Lazzeroni’s contributions have shaped modern breast surgery protocols, offering hope for less invasive yet effective treatment options. His findings continue to influence surgical decision-making and inspire further research into robotic applications in oncology.